GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: CM-4307 | CM4307 | Sorafenib-d3 | Zepsun®
Compound class:
Synthetic organic
Comment: Donafenib (CM-4307) is a deuterated derivative of the approved multikinase inhibitor sorafenib. Like sorafenib, it is orally active. Deuteration improves the stability of drug molecules thus extending half-life and increasing systemic exposure. This means that the effective drug dose may be shifted downward, with an associated improvement in tolerability. The medical formulation is donafenib tosylate.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-(trideuteriomethyl)pyridine-2-carboxamide |
Synonyms ![]() |
| CM-4307 | CM4307 | Sorafenib-d3 | Zepsun® |
Database Links ![]() |
|
| CAS Registry No. | 1130115-44-4 (source: PubChem) |
| ChEMBL Ligand | CHEMBL4297490 |
| DrugBank Ligand | DB15414 |
| GtoPdb PubChem SID | 461663386 |
| PubChem CID | 25191001 |
| Search Google for chemical match using the InChIKey | MLDQJTXFUGDVEO-FIBGUPNXSA-N |
| Search Google for chemicals with the same backbone | MLDQJTXFUGDVEO |
| UniChem Compound Search for chemical match using the InChIKey | MLDQJTXFUGDVEO-FIBGUPNXSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | MLDQJTXFUGDVEO-FIBGUPNXSA-N |